Method for preparing rabies vaccine stock solution from serum-free Vero cells and serum-free rabies vaccine product
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- AB&B BIO TECH CO LTD JS
- Publication Date
- 2017-06-13
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to a preparation method of a rabies vaccine stock solution, in particular to a method for preparing a rabies vaccine stock solution by culturing serum-free Vero cells with bioreactor microcarriers and serum-free rabies vaccine products. Background technique
[0002] At present, the cell substrates used in the mass production of human rabies vaccines include primary cells, such as primary hamster kidney cells (PHKCV) and primary chicken embryo fibroblasts (PCECV); continuous passage cells, such as African green monkey kidney cells (Vero) and human diploid cells, etc. Vero cells are a vaccine production cell line recognized by the World Health Organization. Compared with primary cells, diploid cells and some other passage cell matrices used for vaccine production, Vero cells have the characteristics of continuous passage, fast growth, stable genetic traits, low degree of malignant transformation, high biological safety, and culture...